全身性アスペルギルス症/全身性カンジダ症の世界市場（2024年版）：タイプ別、治療アプローチ別、エンドユーザー別、地域別、国別の分析、市場考察、予測（2020年～2030年）

世界の全身性アスペルギルス症/全身性カンジダ症の市場規模は、2020年～2023年にCAGRで3.62%の成長を示しました。

市場規模は2023年に71億8,000万米ドルであり、2030年までに96億2,000万米ドルに達すると予測されます。特に富裕層の間で可処分所得水準が上昇していることから、高級なアンチエイジング手術やスキンケア製品に対する需要が高まっています。

アスペルギルス症とカンジダ症は、世界でもっとも一般的な真菌感染症の1つであり、移植を受けた患者、化学療法を受けているがん患者、HIV/AIDS患者など、免疫力が低下している人に感染します。これらの感染症は重篤な肺感染症、血流感染症、侵襲性感染症として現れることがあり、速やかに診断および治療されなければ、かなりの罹患率と死亡率をもたらします。

全身性アスペルギルス症/全身性カンジダ症の治療は抗真菌薬が基本となっており、アゾール系、エキノカンディン系、ポリエン系が主な治療オプションとなっています。標準治療が無効な場合や薬剤耐性が現れた場合には、これらの薬剤を併用することもあります。侵襲性肺アスペルギルス症や真菌性心内膜炎などの特定のシナリオでは、補助療法として手術が認められることもあります。

市場は、真菌感染症の増加、診断方法の改良、医療従事者と人々の意識の高まり、抗真菌治療の拡大により勢いを増しています。さらに、高齢化、免疫抑制治療、院内感染などの要因も市場の拡大を後押ししています。

市場は、製薬企業や医療機関を含む主要企業の激しい競合が特徴です。これらの企業は、医療提供者、検査室、患者の進化するニーズに対応するため、継続的に技術革新を行い、新しい製品やソリューションを発表しています。

当レポートでは、世界の全身性アスペルギルス症/全身性カンジダ症市場について調査し、市場規模と予測、地域とセグメントの分析、主要動向と機会などの情報を提供しています。

目次

第1章 市場背景

• 範囲と製品の見通し
• エグゼクティブサマリー
• 調査手法

第2章 アナリストの推奨事項

• 個別化医療
• 新興国市場への進出

第3章 世界の全身性アスペルギルス症/全身性カンジダ症市場：実績と予測

• 世界の全身性アスペルギルス症/全身性カンジダ症市場に対するマクロ経済要因の影響の分析
• 一般的な致死性のある真菌感染症の年間罹患率
• 開発中の全身性アスペルギルス症/全身性カンジダ症向け抗真菌療法
• 世界の全身性アスペルギルス症/全身性カンジダ症市場：ダッシュボード
• 世界の全身性アスペルギルス症/全身性カンジダ症市場：市場規模とCAGR（2020年～2030年）
• 世界の全身性アスペルギルス症/全身性カンジダ症市場：市場金額の評価
• 世界の全身性アスペルギルス症/全身性カンジダ症市場に対するCOVID-19の影響度の評価
• 世界の全身性アスペルギルス症/全身性カンジダ症市場セグメンテーション：タイプ別
  • 世界の全身性アスペルギルス症/全身性カンジダ症市場：タイプ別、概要
  • 世界の全身性アスペルギルス症/全身性カンジダ症市場の魅力指数：タイプ別
  • 世界の全身性アスペルギルス症/全身性カンジダ症の市場規模：カンジダ症（金額）（2020年～2030年）
  • 世界の全身性アスペルギルス症/全身性カンジダ症の市場規模：アスペルギルス症（金額）（2020年～2030年）
• 世界の全身性アスペルギルス症/全身性カンジダ症市場セグメンテーション：治療アプローチ別
  • 世界の全身性アスペルギルス症/全身性カンジダ症市場：治療アプローチ別、概要
  • 世界の全身性アスペルギルス症/全身性カンジダ症市場の魅力指数：治療アプローチ別
  • 世界の全身性アスペルギルス症/全身性カンジダ症の市場規模：抗真菌薬（金額）（2020年～2030年）
  • 世界の全身性アスペルギルス症/全身性カンジダ症の市場規模：併用療法（金額）（2020年～2030年）
  • 世界の全身性アスペルギルス症/全身性カンジダ症の市場規模：手術（金額）（2020年～2030年）
• 世界の全身性アスペルギルス症/全身性カンジダ症市場セグメンテーション：エンドユーザー別
  • 世界の全身性アスペルギルス症/全身性カンジダ症市場の概要：エンドユーザー別
  • 世界の全身性アスペルギルス症/全身性カンジダ症市場の魅力指数：エンドユーザー別
  • 世界の全身性アスペルギルス症/全身性カンジダ症の市場規模：病院（金額）（2020年～2030年）
  • 世界の全身性アスペルギルス症/全身性カンジダ症の市場規模：診療所（金額）（2020年～2030年）
  • 世界の全身性アスペルギルス症/全身性カンジダ症の市場規模：その他のエンドユーザー（金額）（2020年～2030年）

第4章 世界の全身性アスペルギルス症/全身性カンジダ症市場、地域の分析

• 調査の地域範囲
• 地域のスナップショット

第5章 南北アメリカの全身性アスペルギルス症/全身性カンジダ症市場：実績と予測

• 南北アメリカの全身性アスペルギルス症/全身性カンジダ症市場：スナップショット
• 南北アメリカの全身性アスペルギルス症/全身性カンジダ症市場：市場規模とCAGR（2020年～2030年）
• 南北アメリカの全身性アスペルギルス症/全身性カンジダ症市場：主な要因
• 南北アメリカの全身性アスペルギルス症/全身性カンジダ症市場：セグメント分析
• 南北アメリカの全身性アスペルギルス症/全身性カンジダ症市場セグメンテーション：タイプ別
• 南北アメリカの全身性アスペルギルス症/全身性カンジダ症市場セグメンテーション：治療アプローチ別
• 南北アメリカの全身性アスペルギルス症/全身性カンジダ症市場セグメンテーション：エンドユーザー別
• 南北アメリカの全身性アスペルギルス症/全身性カンジダ症市場セグメンテーション：国別
  • 南北アメリカの全身性アスペルギルス症/全身性カンジダ症市場：国別、概要
  • 米国の全身性アスペルギルス症/全身性カンジダ症市場：市場規模とCAGR（2020年～2030年）
  • カナダの全身性アスペルギルス症/全身性カンジダ症市場：市場規模とCAGR（2020年～2030年）
  • その他の南北アメリカの全身性アスペルギルス症/全身性カンジダ症市場：市場規模とCAGR（2020年～2030年）

第6章 欧州の全身性アスペルギルス症/全身性カンジダ症市場：実績と予測

• 欧州の全身性アスペルギルス症/全身性カンジダ症市場：スナップショット
• 欧州の全身性アスペルギルス症/全身性カンジダ症市場：市場規模とCAGR（2020年～2030年）
• 欧州の全身性アスペルギルス症/全身性カンジダ症市場：主な要因
• 欧州の全身性アスペルギルス症/全身性カンジダ症市場：セグメント分析
• 欧州の全身性アスペルギルス症/全身性カンジダ症市場セグメンテーション：タイプ別
• 欧州の全身性アスペルギルス症/全身性カンジダ症市場セグメンテーション：治療アプローチ別
• 欧州の全身性アスペルギルス症/全身性カンジダ症市場セグメンテーション：エンドユーザー別
• 欧州の全身性アスペルギルス症/全身性カンジダ症市場セグメンテーション：国別
  • 欧州の全身性アスペルギルス症/全身性カンジダ症市場：国別、概要
  • ドイツの全身性アスペルギルス症/全身性カンジダ症市場：市場規模とCAGR（2020年～2030年）
  • 英国の全身性アスペルギルス症/全身性カンジダ症市場：市場規模とCAGR（2020年～2030年）
  • フランスの全身性アスペルギルス症/全身性カンジダ症市場：市場規模とCAGR（2020年～2030年）
  • イタリアの全身性アスペルギルス症/全身性カンジダ症市場：市場規模とCAGR（2020年～2030年）
  • スペインの全身性アスペルギルス症/全身性カンジダ症市場：市場規模とCAGR（2020年～2030年）
  • その他の欧州の全身性アスペルギルス症/全身性カンジダ症市場：市場規模とCAGR（2020年～2030年）

第7章 アジア太平洋の全身性アスペルギルス症/全身性カンジダ症市場：実績と予測

• アジア太平洋の全身性アスペルギルス症/全身性カンジダ症市場：スナップショット
• アジア太平洋の全身性アスペルギルス症/全身性カンジダ症市場：市場規模とCAGR（2020年～2030年）
• アジア太平洋の全身性アスペルギルス症/全身性カンジダ症市場：主な要因
• アジア太平洋の全身性アスペルギルス症/全身性カンジダ症市場：セグメント分析
• アジア太平洋の全身性アスペルギルス症/全身性カンジダ症市場セグメンテーション：タイプ別
• アジア太平洋の全身性アスペルギルス症/全身性カンジダ症の市場セグメンテーション：治療アプローチ別
• アジア太平洋の全身性アスペルギルス症/全身性カンジダ症市場セグメンテーション：エンドユーザー別
• アジア太平洋の全身性アスペルギルス症/全身性カンジダ症市場セグメンテーション：国別
  • アジア太平洋の全身性アスペルギルス症/全身性カンジダ症市場：国別、概要
  • 中国の全身性アスペルギルス症/全身性カンジダ症市場：市場規模とCAGR（2020年～2030年）
  • 日本の全身性アスペルギルス症/全身性カンジダ症市場：市場規模とCAGR（2020年～2030年）
  • インドの全身性アスペルギルス症/全身性カンジダ症市場：市場規模とCAGR（2020年～2030年）
  • その他のアジア太平洋の全身性アスペルギルス症/全身性カンジダ症市場：市場規模とCAGR（2020年～2030年）

第8章 中東・アフリカの全身性アスペルギルス症/全身性カンジダ症市場：実績と予測

• 中東・アフリカの全身性アスペルギルス症/全身性カンジダ症市場：スナップショット
• 中東・アフリカの全身性アスペルギルス症/全身性カンジダ症市場：市場規模とCAGR（2020年～2030年）
• 中東・アフリカの全身性アスペルギルス症/全身性カンジダ症市場：主な要因
• 中東・アフリカの全身性アスペルギルス症/全身性カンジダ症市場：セグメント分析
• 中東・アフリカの全身性アスペルギルス症/全身性カンジダ症市場セグメンテーション：タイプ別
• 中東・アフリカの全身性アスペルギルス症/全身性カンジダ症市場セグメンテーション：治療アプローチ別
• 中東・アフリカの全身性アスペルギルス症/全身性カンジダ症市場セグメンテーション：エンドユーザー別

第9章 市場力学

• 全身性アスペルギルス症/全身性カンジダ症市場に対する市場力学の影響の評価
• 促進要因
• 抑制要因
• 動向

第10章 産業エコシステム分析

• ポーター分析

第11章 競合ポジショニング

• 企業の製品ポジショニング
• 市場ポジションマトリクス
• 全身性アスペルギルス症/全身性カンジダ症市場の市場シェア分析
• 企業プロファイル
  • Sanofi
  • Cipla
  • Pfizer
  • GSK PLC
  • Novartis AG
  • Bayer AG
  • Merck & Co., Inc.
  • F. Hoffmann-La Roche AG
  • Abbott Laboratories
  • Gilead Sciences, Inc.

第12章 当社について、免責事項

List of Figures

List of Figures

• Figure 1: Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Value, 2020-2023 (USD Billion)
• Figure 2: Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Value, 2024-2030 (USD Billion)
• Figure 3: Global Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, 2023 (%)
• Figure 4: Market Attractiveness Analysis of Global Systemic Aspergillosis and Systemic Candidiasis Market, By Type (2025-2030)
• Figure 5: Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Candidiasis, By Value, 2020H-2030F (USD Billions & CAGR)
• Figure 6: Global Systemic Aspergillosis and Systemic Candidiasis Market Absolute Opportunity, By Candidiasis, 2020-2030 (USD Billion)
• Figure 7: Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Aspergillosis, By Value, 2020H-2030F (USD Billions & CAGR)
• Figure 8: Global Systemic Aspergillosis and Systemic Candidiasis Market Absolute Opportunity, By Aspergillosis, 2020-2030 (USD Billion)
• Figure 9: Market Attractiveness Analysis of Global Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach (2025-2030)
• Figure 10: Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Antifungal Medications, By Value, 2020H-2030F (USD Billions & CAGR)
• Figure 11: Global Systemic Aspergillosis and Systemic Candidiasis Market Absolute Opportunity, By Antifungal Medications, 2020-2030 (USD Billion)
• Figure 12: Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Combination Therapy, By Value, 2020H-2030F (USD Billions & CAGR)
• Figure 13: Global Systemic Aspergillosis and Systemic Candidiasis Market Absolute Opportunity, By Combination Therapy, 2020-2030 (USD Billion)
• Figure 14: Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Surgical Intervention, By Value, 2020H-2030F (USD Billions & CAGR)
• Figure 15: Global Systemic Aspergillosis and Systemic Candidiasis Market Absolute Opportunity, By Surgical Intervention, 2020-2030 (USD Billion)
• Figure 16: Market Attractiveness Analysis of Global Systemic Aspergillosis and Systemic Candidiasis Market, By End-users (2025-2030)
• Figure 17: Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Hospitals, By Value, 2020H-2030F (USD Billions & CAGR)
• Figure 18: Global Systemic Aspergillosis and Systemic Candidiasis Market Absolute Opportunity, By Hospitals, 2020-2030 (USD Billion)
• Figure 19: Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Clinics, By Value, 2020H-2030F (USD Billions & CAGR)
• Figure 20: Global Systemic Aspergillosis and Systemic Candidiasis Market Absolute Opportunity, By Clinics, 2020-2030 (USD Billion)
• Figure 21: Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Other End-users, By Value, 2020H-2030F (USD Billions & CAGR)
• Figure 22: Global Systemic Aspergillosis and Systemic Candidiasis Market Absolute Opportunity, By Other End-users, 2020-2030 (USD Billion)
• Figure 23: Americas Systemic Aspergillosis and Systemic Candidiasis Market Size, By Value, 2020H-2030F (USD Billion)
• Figure 24: Americas Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, 2023 (%)
• Figure 25: Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Candidiasis, By Value, 2020H-2030F (USD Billions & CAGR)
• Figure 26: Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Aspergillosis, By Value, 2020H-2030F (USD Billions & CAGR)
• Figure 27: Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Antifungal Medications, By Value, 2020H-2030F (USD Billions & CAGR)
• Figure 28: Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Combination Therapy, By Value, 2020H-2030F (USD Billions & CAGR)
• Figure 29: Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Surgical Intervention, By Value, 2020H-2030F (USD Billions & CAGR)
• Figure 30: Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Hospitals, By Value, 2020H-2030F (USD Billions & CAGR)
• Figure 31: Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Clinics, By Value, 2020H-2030F (USD Billions & CAGR)
• Figure 32: Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Other End-users, By Value, 2020H-2030F (USD Billions & CAGR)
• Figure 33: United States Systemic Aspergillosis and Systemic Candidiasis Market, By Value, 2020-2030 (USD Billions & CAGR)
• Figure 34: United States Systemic Aspergillosis and Systemic Candidiasis Market Value, By Treatment Approach, 2023 (USD Billion)
• Figure 35: United States Systemic Aspergillosis and Systemic Candidiasis Market Share, By Type, By Value, 2023 (%)
• Figure 36: United States Systemic Aspergillosis and Systemic Candidiasis Market Share, By Treatment Approach, By Value, 2023 (%)
• Figure 37: United States Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, By Value, 2023 (%)
• Figure 38: Canada Systemic Aspergillosis and Systemic Candidiasis Market, By Value, 2020-2030 (USD Billions & CAGR)
• Figure 39: Canada Systemic Aspergillosis and Systemic Candidiasis Market Value, By Treatment Approach, 2023 (USD Billion)
• Figure 40: Canada Systemic Aspergillosis and Systemic Candidiasis Market Share, By Type, By Value, 2023 (%)
• Figure 41: Canada Systemic Aspergillosis and Systemic Candidiasis Market Share, By Treatment Approach, By Value, 2023 (%)
• Figure 42: Canada Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, By Value, 2023 (%)
• Figure 43: Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Value, 2020-2030 (USD Billions & CAGR)
• Figure 44: Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market Value, By Treatment Approach, 2023 (USD Billion)
• Figure 45: Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market Share, By Type, By Value, 2023 (%)
• Figure 46: Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market Share, By Treatment Approach, By Value, 2023 (%)
• Figure 47: Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, By Value, 2023 (%)
• Figure 48: Europe Systemic Aspergillosis and Systemic Candidiasis Market Size, By Value, 2020H-2030F (USD Billion)
• Figure 49: Europe Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, 2023 (%)
• Figure 50: Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Candidiasis, By Value, 2020H-2030F (USD Billions & CAGR)
• Figure 51: Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Aspergillosis, By Value, 2020H-2030F (USD Billions & CAGR)
• Figure 52: Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Antifungal Medications, By Value, 2020H-2030F (USD Billions & CAGR)
• Figure 53: Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Combination Therapy, By Value, 2020H-2030F (USD Billions & CAGR)
• Figure 54: Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Surgical Intervention, By Value, 2020H-2030F (USD Billions & CAGR)
• Figure 55: Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Hospitals, By Value, 2020H-2030F (USD Billions & CAGR)
• Figure 56: Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Clinics, By Value, 2020H-2030F (USD Billions & CAGR)
• Figure 57: Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Other End-users, By Value, 2020H-2030F (USD Billions & CAGR)
• Figure 58: Germany Systemic Aspergillosis and Systemic Candidiasis Market, By Value, 2020-2030 (USD Billions & CAGR)
• Figure 59: Germany Systemic Aspergillosis and Systemic Candidiasis Market Value, By Treatment Approach, 2023 (USD Billion)
• Figure 60: Germany Systemic Aspergillosis and Systemic Candidiasis Market Share, By Type, By Value, 2023 (%)
• Figure 61: Germany Systemic Aspergillosis and Systemic Candidiasis Market Share, By Treatment Approach, By Value, 2023 (%)
• Figure 62: Germany Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, By Value, 2023 (%)
• Figure 63: United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market, By Value, 2020-2030 (USD Billions & CAGR)
• Figure 64: United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market Value, By Treatment Approach, 2023 (USD Billion)
• Figure 65: United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market Share, By Type, By Value, 2023 (%)
• Figure 66: United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market Share, By Treatment Approach, By Value, 2023 (%)
• Figure 67: United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, By Value, 2023 (%)
• Figure 68: France Systemic Aspergillosis and Systemic Candidiasis Market, By Value, 2020-2030 (USD Billions & CAGR)
• Figure 69: France Systemic Aspergillosis and Systemic Candidiasis Market Value, By Treatment Approach, 2023 (USD Billion)
• Figure 70: France Systemic Aspergillosis and Systemic Candidiasis Market Share, By Type, By Value, 2023 (%)
• Figure 71: France Systemic Aspergillosis and Systemic Candidiasis Market Share, By Treatment Approach, By Value, 2023 (%)
• Figure 72: France Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, By Value, 2023 (%)
• Figure 73: Italy Systemic Aspergillosis and Systemic Candidiasis Market, By Value, 2020-2030 (USD Billions & CAGR)
• Figure 74: Italy Systemic Aspergillosis and Systemic Candidiasis Market Value, By Treatment Approach, 2023 (USD Billion)
• Figure 75: Italy Systemic Aspergillosis and Systemic Candidiasis Market Share, By Type, By Value, 2023 (%)
• Figure 76: Italy Systemic Aspergillosis and Systemic Candidiasis Market Share, By Treatment Approach, By Value, 2023 (%)
• Figure 77: Italy Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, By Value, 2023 (%)
• Figure 78: Spain Systemic Aspergillosis and Systemic Candidiasis Market, By Value, 2020-2030 (USD Billions & CAGR)
• Figure 79: Spain Systemic Aspergillosis and Systemic Candidiasis Market Value, By Treatment Approach, 2023 (USD Billion)
• Figure 80: Spain Systemic Aspergillosis and Systemic Candidiasis Market Share, By Type, By Value, 2023 (%)
• Figure 81: Spain Systemic Aspergillosis and Systemic Candidiasis Market Share, By Treatment Approach, By Value, 2023 (%)
• Figure 82: Spain Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, By Value, 2023 (%)
• Figure 83: Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Value, 2020-2030 (USD Billions & CAGR)
• Figure 84: Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market Value, By Treatment Approach, 2023 (USD Billion)
• Figure 85: Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market Share, By Type, By Value, 2023 (%)
• Figure 86: Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market Share, By Treatment Approach, By Value, 2023 (%)
• Figure 87: Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, By Value, 2023 (%)
• Figure 88: Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Size, By Value, 2020H-2030F (USD Billion)
• Figure 89: Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, 2023 (%)
• Figure 90: Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Candidiasis, By Value, 2020H-2030F (USD Billions & CAGR)
• Figure 91: Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Aspergillosis, By Value, 2020H-2030F (USD Billions & CAGR)
• Figure 92: Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Antifungal Medications, By Value, 2020H-2030F (USD Billions & CAGR)
• Figure 93: Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Combination Therapy, By Value, 2020H-2030F (USD Billions & CAGR)
• Figure 94: Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Surgical Intervention, By Value, 2020H-2030F (USD Billions & CAGR)
• Figure 95: Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Hospitals, By Value, 2020H-2030F (USD Billions & CAGR)
• Figure 96: Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Clinics, By Value, 2020H-2030F (USD Billions & CAGR)
• Figure 97: Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Other End-users, By Value, 2020H-2030F (USD Billions & CAGR)
• Figure 98: China Systemic Aspergillosis and Systemic Candidiasis Market, By Value, 2020-2030 (USD Billions & CAGR)
• Figure 99: China Systemic Aspergillosis and Systemic Candidiasis Market Value, By Treatment Approach, 2023 (USD Billion)
• Figure 100: China Systemic Aspergillosis and Systemic Candidiasis Market Share, By Type, By Value, 2023 (%)
• Figure 101: China Systemic Aspergillosis and Systemic Candidiasis Market Share, By Treatment Approach, By Value, 2023 (%)
• Figure 102: China Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, By Value, 2023 (%)
• Figure 103: Japan Systemic Aspergillosis and Systemic Candidiasis Market, By Value, 2020-2030 (USD Billions & CAGR)
• Figure 104: Japan Systemic Aspergillosis and Systemic Candidiasis Market Value, By Treatment Approach, 2023 (USD Billion)
• Figure 105: Japan Systemic Aspergillosis and Systemic Candidiasis Market Share, By Type, By Value, 2023 (%)
• Figure 106: Japan Systemic Aspergillosis and Systemic Candidiasis Market Share, By Treatment Approach, By Value, 2023 (%)
• Figure 107: Japan Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, By Value, 2023 (%)
• Figure 108: India Systemic Aspergillosis and Systemic Candidiasis Market, By Value, 2020-2030 (USD Billions & CAGR)
• Figure 109: India Systemic Aspergillosis and Systemic Candidiasis Market Value, By Treatment Approach, 2023 (USD Billion)
• Figure 110: India Systemic Aspergillosis and Systemic Candidiasis Market Share, By Type, By Value, 2023 (%)
• Figure 111: India Systemic Aspergillosis and Systemic Candidiasis Market Share, By Treatment Approach, By Value, 2023 (%)
• Figure 112: India Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, By Value, 2023 (%)
• Figure 113: Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Value, 2020-2030 (USD Billions & CAGR)
• Figure 114: Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Value, By Treatment Approach, 2023 (USD Billion)
• Figure 115: Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Share, By Type, By Value, 2023 (%)
• Figure 116: Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Share, By Treatment Approach, By Value, 2023 (%)
• Figure 117: Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, By Value, 2023 (%)
• Figure 118: Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Size, By Value, 2020H-2030F (USD Billion)
• Figure 119: Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, 2023 (%)
• Figure 120: Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market, By Candidiasis, By Value, 2020H-2030F (USD Billions & CAGR)
• Figure 121: Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market, By Aspergillosis, By Value, 2020H-2030F (USD Billions & CAGR)
• Figure 122: Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market, By Antifungal Medications, By Value, 2020H-2030F (USD Billions & CAGR)
• Figure 123: Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market, By Combination Therapy, By Value, 2020H-2030F (USD Billions & CAGR)
• Figure 124: Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market, By Surgical Intervention, By Value, 2020H-2030F (USD Billions & CAGR)
• Figure 125: Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market, By Hospitals, By Value, 2020H-2030F (USD Billions & CAGR)
• Figure 126: Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market, By Clinics, By Value, 2020H-2030F (USD Billions & CAGR)
• Figure 127: Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market, By Other End-users, By Value, 2020H-2030F (USD Billions & CAGR)
• Figure 128: Market Share of Prominent Companies of Systemic Aspergillosis and Systemic Candidiasis Market, 2023 (%)
• Figure 129: Sanofi Revenues, 2020-2022 (USD Million)
• Figure 130: Sanofi Revenues, By Geographic Segments, 2022 (%)
• Figure 131: Sanofi Revenue , By Business Segments, 2022 (%)
• Figure 132: Cipla Revenues, 2020-2022 (USD Million)
• Figure 133: Cipla Revenues, By Geographic Segments, 2022 (%)
• Figure 134: Pfizer Revenues, 2020-2022 (USD Million)
• Figure 135: Pfizer Revenues, By Business Segments, 2023 (%)
• Figure 136: Pfizer Inc. Revenue , By Geographical Segments, 2023 (%)
• Figure 137: GSK PLC Revenue, 2020-2022 (USD Million)
• Figure 138: GSK PLC Revenue , By Business Segments, 2022 (%)
• Figure 139: GSK PLC Revenue, By Geography Segment, 2022 (%)
• Figure 140: Novartis Revenue, 2020-2022 (USD Million)
• Figure 141: Novartis Revenue, By Business Segments, 2022 (%)
• Figure 142: Novartis Revenue, By Geographical Segments, 2022 (%)
• Figure 143: Bayer AG Revenues, 2020-2022 (USD Million)
• Figure 144: Bayer AG Revenues, By Geographic Segments, 2022 (%)
• Figure 145: Bayer AG Revenues, By Business Segments, 2022 (%)
• Figure 146: Merck & Co., Inc. Revenues, 2020-2022 (USD Million)
• Figure 147: Merck & Co., Inc. Revenues, By Geographic Segments, 2022 (%)
• Figure 148: Merck & Co., Inc. Revenue , By Business Segments, 2022 (%)
• Figure 149: Roche Revenues, 2021-2023 (USD Million)
• Figure 150: Roche Revenue , By Sales Division, 2023 (%)
• Figure 151: Roche Revenue , By Geographical Segment, 2023 (%)
• Figure 152: Abbott Laboratories Revenues, 2021-2023 (USD Million)
• Figure 153: Abbott Laboratories Revenues, By Geographic Segments, 2023 (%)
• Figure 154: Abbott Laboratories Revenue , By Business Segments, 2023 (%)
• Figure 155: Gilead Sciences, Inc. Revenues, 2021-2023 (USD Million)
• Figure 156: Gilead Sciences, Inc. Revenues, By Geographic Segments, 2023 (%)
• Figure 157: Gilead Sciences, Inc. Revenue , By Therapeutic Area, 2023 (%)

List of Tables

Table A1: Global Impact of Macro Economic Factors, By Region

Table A2: Annual incidence of commoner life-threatening fungal infections

Table A3: Antifungal Therapies for Systemic Aspergillosis And Systemic Candidiasis in Pipeline

Table A4: United States Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2020-2023 (USD Billion)

Table A5: United States Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2025-2030 (USD Billion)

Table A6: United States Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2020-2023 (USD Billion)

Table A7: United States Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2025-2030 (USD Billion)

Table A8: United States Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2020-2023 (USD Billion)

Table A9: United States Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2025-2030 (USD Billion)

Table A10: Canada Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2020-2023 (USD Billion)

Table A11: Canada Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2025-2030 (USD Billion)

Table A12: Canada Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2020-2023 (USD Billion)

Table A13: Canada Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2025-2030 (USD Billion)

Table A14: Canada Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2020-2023 (USD Billion)

Table A15: Canada Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2025-2030 (USD Billion)

Table A16: Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2020-2023 (USD Billion)

Table A17: Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2025-2030 (USD Billion)

Table A18: Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2020-2023 (USD Billion)

Table A19: Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2025-2030 (USD Billion)

Table A20: Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2020-2023 (USD Billion)

Table A21: Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2025-2030 (USD Billion)

Table A22: Germany Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2020-2023 (USD Billion)

Table A23: Germany Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2025-2030 (USD Billion)

Table A24: Germany Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2020-2023 (USD Billion)

Table A25: Germany Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2025-2030 (USD Billion)

Table A26: Germany Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2020-2023 (USD Billion)

Table A27: Germany Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2025-2030 (USD Billion)

Table A28: United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2020-2023 (USD Billion)

Table A29: United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2025-2030 (USD Billion)

Table A30: United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2020-2023 (USD Billion)

Table A31: United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2025-2030 (USD Billion)

Table A32: United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2020-2023 (USD Billion)

Table A33: United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2025-2030 (USD Billion)

Table A34: France Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2020-2023 (USD Billion)

Table A35: France Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2025-2030 (USD Billion)

Table A36: France Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2020-2023 (USD Billion)

Table A37: France Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2025-2030 (USD Billion)

Table A38: France Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2020-2023 (USD Billion)

Table A39: France Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2025-2030 (USD Billion)

Table A40: Italy Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2020-2023 (USD Billion)

Table A41: Italy Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2025-2030 (USD Billion)

Table A42: Italy Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2020-2023 (USD Billion)

Table A43: Italy Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2025-2030 (USD Billion)

Table A44: Italy Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2020-2023 (USD Billion)

Table A45: Italy Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2025-2030 (USD Billion)

Table A46: Spain Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2020-2023 (USD Billion)

Table A47: Spain Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2025-2030 (USD Billion)

Table A48: Spain Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2020-2023 (USD Billion)

Table A49: Spain Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2025-2030 (USD Billion)

Table A50: Spain Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2020-2023 (USD Billion)

Table A51: Spain Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2025-2030 (USD Billion)

Table A52: Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2020-2023 (USD Billion)

Table A53: Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2025-2030 (USD Billion)

Table A54: Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2020-2023 (USD Billion)

Table A55: Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2025-2030 (USD Billion)

Table A56: Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2020-2023 (USD Billion)

Table A57: Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2025-2030 (USD Billion)

Table A58: China Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2020-2023 (USD Billion)

Table A59: China Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2025-2030 (USD Billion)

Table A60: China Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2020-2023 (USD Billion)

Table A61: China Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2025-2030 (USD Billion)

Table A62: China Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2020-2023 (USD Billion)

Table A63: China Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2025-2030 (USD Billion)

Table A64: Japan Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2020-2023 (USD Billion)

Table A65: Japan Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2025-2030 (USD Billion)

Table A66: Japan Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2020-2023 (USD Billion)

Table A67: Japan Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2025-2030 (USD Billion)

Table A68: Japan Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2020-2023 (USD Billion)

Table A69: Japan Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2025-2030 (USD Billion)

Table A70: India Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2020-2023 (USD Billion)

Table A71: India Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2025-2030 (USD Billion)

Table A72: India Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2020-2023 (USD Billion)

Table A73: India Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2025-2030 (USD Billion)

Table A74: India Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2020-2023 (USD Billion)

Table A75: India Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2025-2030 (USD Billion)

Table A76: Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2020-2023 (USD Billion)

Table A77: Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2025-2030 (USD Billion)

Table A78: Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2020-2023 (USD Billion)

Table A79: Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2025-2030 (USD Billion)

Table A80: Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2020-2023 (USD Billion)

Table A81: Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2025-2030 (USD Billion)

Table A82: Sanofi Key Financials, 2020-2022

Table A83: Cipla Key Financials, 2020-2022

Table A84: Pfizer Key Financials, 2021-2023

Table A85: GSK PLC Key Company Financials, 2020-2022

Table A86: Novartis Key Company Financials, 2020-2022

Table A87: Bayer AG Key Financials, 2020-2022

Table A88: Merck & Co., Inc. Key Financials, 2020-2022

Table A89: Roche Key Financials, 2021-2023

Table A90: Abbott Laboratories Key Financials, 2021-2023

Table A91: Gilead Sciences, Inc. Key Financials, 2021-2023

Executive Summary

Azoth Analytics has released a research report titled "Global Systemic Aspergillosis and Systemic Candidiasis Market (2024 Edition)" which provides a complete analysis of the Global Systemic Aspergillosis and Systemic Candidiasis industry in terms of market segmentation By Type (Candidiasis, Aspergillosis), By Treatment Approach (Antifungal Medications, Combination Therapy, and Surgical Intervention) By End Users (Hospitals, Clinics, Other End-users) for the historical period of 2020-2023, the estimates of 2024 and the forecast period of 2025-2030.

The report analyses the Global Systemic Aspergillosis and Systemic Candidiasis Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India). The Global Systemic Aspergillosis and Systemic Candidiasis market showcased growth at a CAGR of 3.62% during 2020-2023.

The market was valued at USD 7.18 Billion in 2023 which is expected to reach USD 9.62 Billion in 2030. Growing disposable income levels, particularly among affluent consumers, have fuelled demand for premium anti-aging Surgical Intervention and skincare products.

Aspergillosis and candidiasis are among the most common fungal infections worldwide, affecting individuals with compromised immune systems, such as transplant recipients, cancer patients

undergoing chemotherapy, and those with HIV/AIDS. These infections can manifest as severe pulmonary, bloodstream, or invasive infections, leading to substantial morbidity and mortality if not promptly diagnosed and treated.

Antifungal drugs continue to serve as the foundation for treating systemic aspergillosis and systemic candidiasis, with azoles, echinocandins, and polyenes representing the primary

treatment options. Combinations of these medications may be utilized in cases where standard therapy proves ineffective or to combat instances of emerging drug resistance. In certain

scenarios, such as invasive pulmonary aspergillosis or fungal endocarditis, surgical procedures may be warranted as adjunctive therapy.

The Global Systemic Aspergillosis and Systemic Candidiasis Market experiences momentum due to rising occurrences of fungal infections, improved diagnostic methods, heightened awareness among healthcare practitioners and individuals, and the expanding array of antifungal treatments. Furthermore, factors such as population aging, immunosuppressive treatments, and hospital- acquired transmissions bolster the market's expansion.

The market is characterized by intense competition among key players, including pharmaceutical companies, and healthcare organizations. These companies are continuously innovating and launching new products and solutions to meet the evolving needs of healthcare providers, laboratories, and patients.

Scope of the Report:

• The report analyses the Systemic Aspergillosis and Systemic Candidiasis Market by Value (USD Billion).
• The report analyses the Systemic Aspergillosis and Systemic Candidiasis Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada,

Germany, United Kingdom, France, Italy, Spain, China, Japan, India).

• The report presents the analysis of Systemic Aspergillosis and Systemic Candidiasis Market for the historical period of 2020-2023, the estimated year 2024 and the forecast period of 2025-2030.
• The report analyses the Systemic Aspergillosis and Systemic Candidiasis Market By Type (Candidiasis, Aspergillosis)
• The report analyses the Systemic Aspergillosis and Systemic Candidiasis Market By Treatment Approach (Antifungal Medications, Combination Therapy, and Surgical Intervention).
• The report analyses the Systemic Aspergillosis and Systemic Candidiasis Market By End Users (Hospitals, Clinics, and Other End Users).
• The key insights of the report have been presented through the frameworks of SWOT and Porter's Five Forces Analysis. Also, the attractiveness of the market has been presented by region, By Type, By Treatment Approach and By End User.
• Also, the major opportunities, trends, drivers, and challenges of the industry has been analyzed in the report.
• The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Sanofi, Cipla, Pfizer, GSK PLC, Novartis AG, Bayer AG, Merck & Co., Inc., F. Hoffmann-La Roche AG, Abbott Laboratories and Gilead Sciences, Inc.

Table of Contents

Table of Content

1. Market Background

• 1.1 Scope and Product Outlook
• 1.2 Executive Summary
• 1.3 Research Methodology

2. Analyst Recommendations

• 2.1 Personalized Medicine
• 2.2 Penetrating Developing Markets

3. Global Systemic Aspergillosis and Systemic Candidiasis Market: Historic and Forecast

• 3.1 Impact Analysis of Macro Economic Factors on Global Systemic Aspergillosis and Systemic Candidiasis Market
• 3.2 Annual incidence of commoner life-threatening fungal infections
• 3.3 Antifungal Therapies for Systemic Aspergillosis And Systemic Candidiasis in Pipeline
• 3.4 Global Systemic Aspergillosis and Systemic Candidiasis Market: Dashboard
• 3.5 Global Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
• 3.6 Global Systemic Aspergillosis and Systemic Candidiasis Market: Market Value Assessment
• 3.7 Assessment Degree of Impact of COVID-19 on Global Systemic Aspergillosis and Systemic Candidiasis Market
• 3.8 Global Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Type
  • 3.8.1 Global Systemic Aspergillosis and Systemic Candidiasis Market, By Type Overview
  • 3.8.2 Global Systemic Aspergillosis and Systemic Candidiasis Market Attractiveness Index, By Type
  • 3.8.3 Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Candidiasis, By Value, 2020H-2030F (USD Billion & CAGR)
  • 3.8.4 Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Aspergillosis, By Value, 2020H-2030F (USD Billion & CAGR)
• 3.9 Global Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Treatment Approach
  • 3.9.1 Global Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach Overview
  • 3.9.2 Global Systemic Aspergillosis and Systemic Candidiasis Market Attractiveness Index, By Treatment Approach
  • 3.9.3 Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Antifungal Medications, By Value, 2020H-2030F (USD Billion & CAGR)
  • 3.9.4 Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Combination Therapy, By Value, 2020H-2030F (USD Billion & CAGR)
  • 3.9.5 Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Surgical Intervention, By Value, 2020H-2030F (USD Billion & CAGR)
• 3.10 Global Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By End-users
  • 3.10.1 Global Systemic Aspergillosis and Systemic Candidiasis Market, By End-users Overview
  • 3.10.2 Global Systemic Aspergillosis and Systemic Candidiasis Market Attractiveness Index, By End-users
  • 3.10.3 Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Hospitals, By Value, 2020H-2030F (USD Billion & CAGR)
  • 3.10.4 Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Clinics, By Value, 2020H-2030F (USD Billion & CAGR)
  • 3.10.5 Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Other End-users, By Value, 2020H-2030F (USD Billion & CAGR)

4. Global Systemic Aspergillosis and Systemic Candidiasis Market, Region Analysis

• 4.1 Regional Coverage of the Study
• 4.2 Regional Snapshot

5. Americas Systemic Aspergillosis and Systemic Candidiasis Market: Historic and Forecast

• 5.1 Americas Systemic Aspergillosis and Systemic Candidiasis Market: Snapshot
• 5.2 Americas Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
• 5.3 Americas Systemic Aspergillosis and Systemic Candidiasis Market: Key Factors
• 5.4 Americas Systemic Aspergillosis and Systemic Candidiasis Market: Segment Analysis
• 5.5 Americas Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Type
  • 5.5.1 Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Type Overview
  • 5.5.2 Americas Systemic Aspergillosis and Systemic Candidiasis Market Size, By Candidiasis, By Value, 2020H-2030F (USD Billion & CAGR)
  • 5.5.3 Americas Systemic Aspergillosis and Systemic Candidiasis Market Size, By Aspergillosis, By Value, 2020H-2030F (USD Billion & CAGR)
• 5.6 Americas Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: Treatment Approach
  • 5.6.1 Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach Overview
  • 5.6.2 Americas Systemic Aspergillosis and Systemic Candidiasis Market Size, By Antifungal Medications, By Value, 2020H-2030F (USD Billion & CAGR)
  • 5.6.3 Americas Systemic Aspergillosis and Systemic Candidiasis Market Size, By Combination Therapy, By Value, 2020H-2030F (USD Billion & CAGR)
  • 5.6.4 Americas Systemic Aspergillosis and Systemic Candidiasis Market Size, By Surgical Intervention, By Value, 2020H-2030F (USD Billion & CAGR)
• 5.7 Americas Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By End-users
  • 5.7.1 Americas Systemic Aspergillosis and Systemic Candidiasis Market, By End-users Overview
  • 5.7.2 Americas Systemic Aspergillosis and Systemic Candidiasis Market Size, By Hospitals, By Value, 2020H-2030F (USD Billion & CAGR)
  • 5.7.3 Americas Systemic Aspergillosis and Systemic Candidiasis Market Size, By Clinics, By Value, 2020H-2030F (USD Billion & CAGR)
  • 5.7.4 Americas Systemic Aspergillosis and Systemic Candidiasis Market Size, By Other End-users, By Value, 2020H-2030F (USD Billion & CAGR)
• 5.8 Americas Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Country
  • 5.8.1 Americas Systemic Aspergillosis and Systemic Candidiasis Market, by Country Overview
  • 5.8.2 United States Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
    • 5.8.2.1 United States Systemic Aspergillosis and Systemic Candidiasis Market, By Type
    • 5.8.2.2 United States Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
    • 5.8.2.3 United States Systemic Aspergillosis and Systemic Candidiasis Market, By End-users
  • 5.8.3 Canada Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
    • 5.8.3.1 Canada Systemic Aspergillosis and Systemic Candidiasis Market, By Type
    • 5.8.3.2 Canada Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
    • 5.8.3.3 Canada Systemic Aspergillosis and Systemic Candidiasis Market, By End-users
  • 5.8.4 Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
    • 5.8.4.1 Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Type
    • 5.8.4.2 Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
    • 5.8.4.3 Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market, By End-users

6. Europe Systemic Aspergillosis and Systemic Candidiasis Market: Historic and Forecast

• 6.1 Europe Systemic Aspergillosis and Systemic Candidiasis Market: Snapshot
• 6.2 Europe Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
• 6.3 Europe Systemic Aspergillosis and Systemic Candidiasis Market: Key Factors
• 6.4 Europe Systemic Aspergillosis and Systemic Candidiasis Market: Segment Analysis
• 6.5 Europe Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Type
  • 6.5.1 Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Type Overview
  • 6.5.2 Europe Systemic Aspergillosis and Systemic Candidiasis Market Size, By Candidiasis, By Value, 2020H-2030F (USD Billion & CAGR)
  • 6.5.3 Europe Systemic Aspergillosis and Systemic Candidiasis Market Size, By Aspergillosis, By Value, 2020H-2030F (USD Billion & CAGR)
• 6.6 Europe Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Treatment Approach
  • 6.6.1 Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach Overview
  • 6.6.2 Europe Systemic Aspergillosis and Systemic Candidiasis Market Size, By Antifungal Medications, By Value, 2020H-2030F (USD Billion & CAGR)
  • 6.6.3 Europe Systemic Aspergillosis and Systemic Candidiasis Market Size, By Combination Therapy, By Value, 2020H-2030F (USD Billion & CAGR)
  • 6.6.3 Europe Systemic Aspergillosis and Systemic Candidiasis Market Size, By Surgical Intervention, By Value, 2020H-2030F (USD Billion & CAGR)
• 6.7 Europe Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By End-users
  • 6.7.1 Europe Systemic Aspergillosis and Systemic Candidiasis Market, By End-users Overview
  • 6.7.2 Europe Systemic Aspergillosis and Systemic Candidiasis Market Size, By Hospitals, By Value, 2020H-2030F (USD Billion & CAGR)
  • 6.7.3 Europe Systemic Aspergillosis and Systemic Candidiasis Market Size, By Clinics, By Value, 2020H-2030F (USD Billion & CAGR)
  • 6.7.4 Europe Systemic Aspergillosis and Systemic Candidiasis Market Size, By Other End-users, By Value, 2020H-2030F (USD Billion & CAGR)
• 6.8 Europe Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Country
  • 6.8.1 Europe Systemic Aspergillosis and Systemic Candidiasis Market, by Country Overview
  • 6.8.2 Germany Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
    • 6.8.2.1 Germany Systemic Aspergillosis and Systemic Candidiasis Market, By Type
    • 6.8.2.2 Germany Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
    • 6.8.2.3 Germany Systemic Aspergillosis and Systemic Candidiasis Market, By End-users
  • 6.8.3 United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
    • 6.8.3.1 United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market, By Type
    • 6.8.3.2 United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
    • 6.8.3.3 United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market, By End-users
  • 6.8.4 France Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
    • 6.8.4.1 France Systemic Aspergillosis and Systemic Candidiasis Market, By Type
    • 6.8.4.2 France Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
    • 6.8.4.3 France Systemic Aspergillosis and Systemic Candidiasis Market, By End-users
  • 6.8.5 Italy Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
    • 6.8.5.1 Italy Systemic Aspergillosis and Systemic Candidiasis Market, By Type
    • 6.8.5.2 Italy Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
    • 6.8.5.3 Italy Systemic Aspergillosis and Systemic Candidiasis Market, By End-users
  • 6.8.6 Spain Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
    • 6.8.6.1 Spain Systemic Aspergillosis and Systemic Candidiasis Market, By Type
    • 6.8.6.2 Spain Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
    • 6.8.6.3 Spain Systemic Aspergillosis and Systemic Candidiasis Market, By End-users
  • 6.8.7 Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
    • 6.8.7.1 Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Type
    • 6.8.7.2 Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
    • 6.8.7.3 Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market, By End-users

7. Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market: Historic and Forecast

• 7.1 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market: Snapshot
• 7.2 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
• 7.3 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market: Key Factors
• 7.4 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market: Segment Analysis
• 7.5 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Type
  • 7.5.1 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Type Overview
  • 7.5.2 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Size, By Candidiasis, By Value, 2020H-2030F (USD Billion & CAGR)
  • 7.5.3 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Size, By Aspergillosis, By Value, 2020H-2030F (USD Billion & CAGR)
• 7.6 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Treatment Approach
  • 7.6.1 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach Overview
  • 7.6.2 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Size, By Antifungal Medications, By Value, 2020H-2030F (USD Billion & CAGR)
  • 7.6.3 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Size, By Combination Therapy, By Value, 2020H-2030F (USD Billion & CAGR)
  • 7.6.3 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Size, By Surgical Intervention, By Value, 2020H-2030F (USD Billion & CAGR)
• 7.7 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By End-users
  • 7.7.1 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By End-users Overview
  • 7.7.2 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Size, By Hospitals, By Value, 2020H-2030F (USD Billion & CAGR)
  • 7.7.3 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Size, By Clinics, By Value, 2020H-2030F (USD Billion & CAGR)
  • 7.7.4 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Size, By Other End-users, By Value, 2020H-2030F (USD Billion & CAGR)
• 7.8 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Country
  • 7.8.1 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, by Country Overview
  • 7.8.2 China Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
    • 7.8.2.1 China Systemic Aspergillosis and Systemic Candidiasis Market, By Type
    • 7.8.2.2 China Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
    • 7.8.2.3 China Systemic Aspergillosis and Systemic Candidiasis Market, By End-users
  • 7.8.3 Japan Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
    • 7.8.3.1 Japan Systemic Aspergillosis and Systemic Candidiasis Market, By Type
    • 7.8.3.2 Japan Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
    • 7.8.3.3 Japan Systemic Aspergillosis and Systemic Candidiasis Market, By End-users
  • 7.8.4 India Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
    • 7.8.4.1 India Systemic Aspergillosis and Systemic Candidiasis Market, By Type
    • 7.8.4.2 India Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
    • 7.8.4.3 India Systemic Aspergillosis and Systemic Candidiasis Market, By End-users
  • 7.8.5 Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
    • 7.8.5.1 Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Type
    • 7.8.5.2 Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
    • 7.8.5.3 Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By End-users

8. Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market: Historic and Forecast

• 8.1 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market: Snapshot
• 8.2 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
• 8.3 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market: Key Factors
• 8.4 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market: Segment Analysis
• 8.5 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Type
  • 8.5.1 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market, By Type Overview
  • 8.5.2 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Size, By Candidiasis, By Value, 2020H-2030F (USD Billion & CAGR)
  • 8.5.3 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Size, By Aspergillosis, By Value, 2020H-2030F (USD Billion & CAGR)
• 8.6 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Treatment Approach
  • 8.6.1 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach Overview
  • 8.6.2 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Size, By Antifungal Medications, By Value, 2020H-2030F (USD Billion & CAGR)
  • 8.6.3 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Size, By Combination Therapy, By Value, 2020H-2030F (USD Billion & CAGR)
  • 8.6.3 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Size, By Surgical Intervention, By Value, 2020H-2030F (USD Billion & CAGR)
• 8.7 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By End-users
  • 8.7.1 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market, By End-users Overview
  • 8.7.2 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Size, By Hospitals, By Value, 2020H-2030F (USD Billion & CAGR)
  • 8.7.3 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Size, By Clinics, By Value, 2020H-2030F (USD Billion & CAGR)
  • 8.7.4 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Size, By Other End-users, By Value, 2020H-2030F (USD Billion & CAGR)

9. Market Dynamics

• 9.1 Impact assessment of Market Dynamics on Systemic Aspergillosis and Systemic Candidiasis Market
• 9.2 Drivers
• 9.3 Restraints
• 9.4 Trends

10. Industry Ecosystem Analysis

• 10.1 Porter Analysis

11. Competitive Positioning

• 11.1 Companies' Product Positioning
• 11.2 Market Position Matrix
• 11.3 Market Share Analysis of Systemic Aspergillosis and Systemic Candidiasis Market
• 11.4 Company Profiles
  • 11.4.1 Sanofi
  • 11.4.2 Cipla
  • 11.4.3 Pfizer
  • 11.4.4 GSK PLC
  • 11.4.5 Novartis AG
  • 11.4.6 Bayer AG
  • 11.4.7 Merck & Co., Inc.
  • 11.4.8 F. Hoffmann-La Roche AG
  • 11.4.9 Abbott Laboratories
  • 11.4.10 Gilead Sciences, Inc.

12. About Us & Disclaimer